QIAGEN N.V. to release results for Q2 2024 and hold webcast
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
QIAGEN N.V. (NYSE: QGEN) will release its Q2 2024 financial results on July 31, 2024, just after 22:05 Frankfurt time, 21:05 London time, and 16:05 New York time. The company will hold a conference call discussing the results on August 1, 2024, at 15:00 Frankfurt time, 14:00 London time, and 09:00 New York time. Participants can join via a call-back service, dial-in by phone, or access an audio webcast. Registration for call-back and webcast access is available 15 minutes before the call starts. A replay of the conference call will be accessible via a web link.
Positive
- QIAGEN N.V. schedules Q2 2024 financial results release, indicating transparency and commitment to shareholders.
- The company provides multiple options for stakeholders to participate in the conference call, enhancing accessibility.
Negative
- None.
Details
News Market Reaction – QGEN
The recorded move for QGEN in the trading session of this news was +1.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Venlo, The Netherlands, July 02, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the second quarter 2024.
Press release date / time: Wednesday, July 31, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.
Conference call date / time: Thursday, August 1, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.
Three options for joining the conference call
Register for call back connection - Click here: Connect me
Service is available 15 minutes before the call starts
Dial-in by phone
U.S.: +1 646 828 8193
UK: +44 (0)330 165 3655
GER: +49 (0)69 6610 2492
Conference ID: 8081810
To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Access the audio webcast - Click here: Access Webcast
A conference call replay will be available by using the following link:
https://event.webcasts.com/starthere.jsp?ei=1643476&tp_key=e15f4dcc6b
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample
to Insight solutions that enable customers to gain valuable molecular insights from samples
containing the building blocks of life. Our sample technologies isolate and process DNA,
RNA and proteins from blood, tissue and other materials. Assay technologies make these
biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases
interpret data to report relevant, actionable insights. Automation solutions tie these together
in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000
customers around the world in the Life Sciences (academia, pharma R&D and industrial applications,
primarily forensic) and Molecular Diagnostics (human healthcare).
As of March 31, 2024, QIAGEN employed 6,000 people in over 35 locations worldwide.
Further information can be found at http://www.qiagen.com.
source: QIAGEN N.V.
category: Financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.